In the research conducted by D. Miller et al., inhibiting ACSS2 was found to transform cancer cells from acetate consumers to producers, thereby making acetate available as a fuel source for tumor-infiltrating lymphocytes. The gene discussed is ACSS2; the disease is cancer.